Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Cannabis Industry Confronts Billion-Dollar Threat: Weak Weed
A pathogen spreading among crops is cutting the recreational drug’s potency, forcing growers to cull “dudded” plants. Source link
The First Smart Gun Is Finally Coming to Market. Will Anyone Buy It?
The weapon, which can only be fired by an authorized user, has been in development since the 1990s. Source link
Hedge Funds Seek to Cut Off $1 Billion Meant for Opioid Victims
Drugmaker Mallinckrodt is talking to hedge funds about filing for bankruptcy and avoiding payments intended to help people addicted to opioids. Source link
U.K. Reviews Safety of Ozempic, Other Weight-Loss Drugs
Drug regulators said they have received several reports of suspected suicidal and self-injurious behavior in patients taking the drugs. Source link
Elon Musk's X Rebrand Cues Complications—and Porn Jokes
The latest Twitter upheaval has agitated former employees and could incite trademark battles. Source link
The Hidden Career Cost of Being Overweight
New moves to outlaw weight discrimination are pushing companies to examine one of the most insidious forms of on-the-job bias. Source link
Homeowners Don't Want to Sell, So Home Builders Are Booming
High mortgage rates are dissuading sellers, leaving new construction the only game in town. ‘There was no inventory on the existing market, so everybody was
Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.
Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago. Source link
Eli Lilly to Acquire Versanis Bio, Maker of Obesity Treatment
Versanis shareholders could receive as much as $1.925 billion in cash, which will consist of an upfront payment and additional payments if certain milestones are
Republican Attorneys General Warn Top U.S. Businesses Over 'Discrimination'
Citing the affirmative action ruling, top state law officials put Fortune 100 companies on notice for racial quotas, preferences Source link